ACTIVE IMMUNOTHERAPY FOR CANCER
- 29 September 1973
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 302 (7831) , 737-738
- https://doi.org/10.1016/s0140-6736(73)92571-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Routine application of the nitroblue tetrazolium test in the clinical laboratoryJournal of Clinical Pathology, 1973
- Lymphocyte reactivity in cancer patients: Correlation with tumor histology and clinical stageCancer, 1973
- Immunologic Response of Cancer Patients Modified by Immunization with Tumor VaccineAnnals of Surgery, 1972
- Recent Advances in OncologyAnnals of Internal Medicine, 1972
- Immunological Effects of BCG in Malignant Melanoma: Two Modes of Administration ComparedAnnals of Internal Medicine, 1972
- LEUKÆMIA AND B.C.G.: A Controlled TrialThe Lancet, 1971
- Nitroblue tetrazolium dye test as an aid in thedifferential diagnosis of febrile disordersThe Journal of Pediatrics, 1971
- B.C.G. VACCINATION AND LEUKÆMIA MORTALITYThe Lancet, 1970
- B.C.G. VACCINATION AND LEUKÆMIA MORTALITYThe Lancet, 1970
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969